Open House Drug Rebate Agreements Lamotrigine, ATC N03AX09
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Lamotrigin, ATC N03AX09
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
Open-house model provides no exclusivity; other buyers may have separate contracts. This may limit demand.
Administrative burden of paper submission (two originals) or requiring qualified electronic signature.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until May 2027
- Supply of pharmaceutical products containing Lamotrigine (ATC N03AX09)
- Non-exclusive rebate agreement under §130a Abs. 8 SGB V
Show full summary
Open-house model for non-exclusive drug rebate agreements for Lamotrigine (ATC N03AX09) with AOK Bayern. All eligible pharmaceutical companies can join. No competitive selection; contracts are identical and non-negotiable. Duration: 01.06.2025 to 31.05.2027. Applications accepted until 05.04.2027. No estimated value published.
Risks
Open-house model provides no exclusivity; other buyers may have separate contracts. This may limit demand.
Administrative burden of paper submission (two originals) or requiring qualified electronic signature.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' required.
Eligibility
- Only pharmaceutical companies are eligible.
Administrative
- Must submit signed self-declaration of reliability.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Drug Rebate Agreements Lamotrigine, ATC N03AX09
Non-exclusive rebate agreements for the active substance Lamotrigine. All interested pharmaceutical companies meeting eligibility criteria may sign identical contracts. The contract start is flexible (earliest 01.06.2025) and ends 31.05.2027.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Lamotrigin, ATC N03AX09
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Procurement Details
- Publication date
- 15 Apr 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 247124-2025
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
Open-house model provides no exclusivity; other buyers may have separate contracts. This may limit demand.
Administrative burden of paper submission (two originals) or requiring qualified electronic signature.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications